AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amphastar Pharmaceuticals, Inc. Director's Dealing 2016

Mar 30, 2016

10216_dirs_2016-03-29_2c5baaeb-aeb5-4477-ad41-b038efe79f08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2016-03-26

Reporting Person: Shandell Jason B. (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-26	Common Stock	F	4714	$11.96	Disposed	233526	Direct
2016-03-27	Common Stock	F	5938	$11.96	Disposed	227588	Direct

Footnotes

F1: The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of deferred stock units, or DSUs.